Showing results (231-240 of 590) with videos related to
Sort By:
Pageof 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II StudyMichael B Atkins, Gwenaelle Gravis, Kazimierz Drosik, et al.Organic Letters|May 24, 2024
General and Scalable Synthesis of 2-Aryl and 2-Alkyl Pyrimidines via an Electronically Tuned SNAr ApproachChandrasekhar Navuluri, Hsin Y Su, Ryan J Sullivan, et al.Journal for Immunotherapy of Cancer|March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitorsHarriet Kluger, J Carl Barrett, Justin F Gainor, et al.Cancer|June 11, 2015
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinomaM Dror Michaelson, Rana R McKay, Lillian Werner, et al.Cancer|September 16, 2008
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group studyMichael B Atkins, Jeffrey A Sosman, Sanjiv Agarwala, et al.International Journal of Surgery (London, England)|May 3, 2023
Toxicities associated with immune checkpoint inhibitors: a systematic studyXiangyi Kong, Li Chen, Zhaohui Su, et al.British Journal of Cancer|August 23, 2022
Clinical and genomic correlates of imatinib response in melanomas with KIT alterationsSeungyeon Jung, Emma Armstrong, Alexander Z Wei, et al.Translational Oncology|April 8, 2014
The role of angiopoietins as potential therapeutic targets in renal cell carcinomaXiaoen Wang, Andrea J Bullock, Liang Zhang, et al.Journal for Immunotherapy of Cancer|March 6, 2019
Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitorsSuthee Rapisuwon, Benjamin Izar, Cory Batenchuk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanomaSteven J O'Day, Michael B Atkins, Peter Boasberg, et al.Pageof 59